drugset / Trial / NCT00795223

Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA

NCT00795223 ↗

Phase 4 Completed 160 enrolled Mahidol University Siriraj Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block

Timeline

Start
2008-10
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % —
Comparator Bupivacaine Other / unclassified 0.5 % —
Comparator Morphine Other / unclassified 0.2 mg Intrathecal
Comparator Morphine Other / unclassified 0.3 mg Intrathecal

Indications

No indication recorded.